PRWeb: Medical CancerLatest news releases for Medical Cancer from PRWebThis Summer Remember That Sunscreen Is No Longer Enough -- People Spending Time In The Sun Should Consider Sun Protective Clothing- (Found July 5, 2008 ) Most adults recognize the extreme dangers from excessive sun exposure and take precautions by using sunscreen when spending time outdoors, especially during the summer months. However, with the continuing depletion of the ozone, it is important to consider the protection the body is getting from clothing. (PRWeb Jul 1, 2008) Read the full story at http:www.prweb.comreleases200807prweb1062394.htmhttp://www.prweb.com/releases/2008/07/prweb1062394.htm TomoTherapy Concludes Treatment Quality Challenge- (Found July 5, 2008 ) TomoTherapy Incorporated (NASDAQ:TOMO), maker of the TomoTherapy&174; Hi&183;Art&174; treatment system for advanced radiation therapy, today announced the close of its Treatment Quality Challenge. The company had offered $250,000 to any U.S. cancer center that could surpass the quality of a helical TomoTherapySM treatment plan using a single-rotation Varian RapidArc&8482; plan delivered in two minutes or less. The three-month program ended on June 30, 2008, without a single entry. (PRWeb Jul...http://www.prweb.com/releases/tomotherapy/treatment/prweb1069804.htm Anadis' Cancer Related Mucositis Project Awarded with VISTECH Grant- (Found July 5, 2008 ) Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian biopharmaceutical company has been awarded a product development grant for its Cancer-related Alimentary Mucositis project. The award was one of only three made by the VISTECH bi-national fund, following a competitive process, which included a thorough scientific assessment. The fund was established by the Government of Victoria (Australia) and the Government of Israel through the Office of the Chief Scientist in its Ministry of Industry Trade and..http://www.prweb.com/releases/mucositis/cancer/prweb1073034.htm TomoTherapy Tops MD Buyline Rankings for Second Straight Quarter- (Found July 5, 2008 ) TomoTherapy Incorporated (NASDAQ: TOMO), maker of the TomoTherapy&174; Hi&183;Art&174; treatment system for advanced radiation therapy, has earned top honors in MD Buyline&8217;s user satisfaction rankings for the second consecutive quarter, solidifying its position as the customer service leader in linear accelerator-based radiation therapy. (PRWeb Jul 2, 2008) Read the full story at http:www.prweb.comreleasestomotherapymd_buylineprweb1072684.htmhttp://www.prweb.com/releases/tomotherapy/md_buyline/prweb1072684.htm |